NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-048-2012-0-PCT-02 Expression Of Protein-coding And Noncoding Genes As A Prognostic Classifier In Early. Stage, Lung Adenocarcinoma PCT PCT PCT/US2013/055746 Expired
NIDDK E-231-2012-0-EP-03 Capillary Viscometer and Multiscale Pressure Differential Measuring Device EP National Stage 13831132.9 Abandoned
NIDDK E-231-2012-0-PCT-02 Capillary Viscometer and Multiscale Pressure Differential Measuring Device PCT PCT PCT/US2013/055786 Expired
NCI E-121-2015-0-US-01 Inhibition Of Plasminogen Activator Inhibitor-1 (PAI-1) Activity Mitigates Radiation Fibrosis US 61/867,801 Abandoned
NIAMS E-210-2009-0-US-04 Disabling Autophagy as a Treatment For Lysosomal Storage Diseases US CON 13/970,265 Abandoned
NCI E-198-2012-0-CA-04 MESOTHELIN DOMAIN-SPECIFIC MONOCLONAL ANTIBODIES AND USE THEREOF CA National Stage 2882753 Issued
NCI E-198-2012-0-EP-12 MESOTHELIN DOMAIN-SPECIFIC MONOCLONAL ANTIBODIES AND USE THEREOF EP DIV 17210140.4 Issued
NCI E-198-2012-0-DE-15 MESOTHELIN DOMAIN-SPECIFIC MONOCLONAL ANTIBODIES AND USE THEREOF DE EP 17210140.4 Issued
NCI E-198-2012-0-FR-14 MESOTHELIN DOMAIN-SPECIFIC MONOCLONAL ANTIBODIES AND USE THEREOF FR EP 17210140.4 Issued
NCI E-198-2012-0-GB-16 MESOTHELIN DOMAIN-SPECIFIC MONOCLONAL ANTIBODIES AND USE THEREOF GB EP 17210140.4 Issued
NCI E-198-2012-0-AU-13 MESOTHELIN DOMAIN-SPECIFIC MONOCLONAL ANTIBODIES AND USE THEREOF AU DIV 2018202446 Issued
NCI E-198-2012-0-AU-03 MESOTHELIN DOMAIN-SPECIFIC MONOCLONAL ANTIBODIES AND USE THEREOF AU National Stage 2013306076 Issued
NCI E-198-2012-0-EP-05 MESOTHELIN DOMAIN-SPECIFIC MONOCLONAL ANTIBODIES AND USE THEREOF EP National Stage 13753475.6 Issued
NCI E-025-2009-0-GB-27 Ratio Based Biomarkers And Methods of Use Thereof GB EP 13180760.4 Issued
NCI E-025-2009-0-FR-26 Ratio Based Biomarkers And Methods of Use Thereof FR EP 13180760.4 Issued
NCI E-025-2009-0-DE-25 Ratio Based Biomarkers And Methods of Use Thereof DE EP 13180760.4 Issued
NIDDK E-260-2012-0-EP-03 Cyclopentane-Peptide Nucleic Acids For Qualitative And Quantitative Detection Of Nucleic Acids EP National Stage 13753962.3 Issued
NCI E-052-2013-0-PCT-02 Use Of Argon As A Tissue Fixation Preservative PCT PCT PCT/US2013/55337 Expired
NCI E-198-2012-0-PCT-02 MESOTHELIN DOMAIN-SPECIFIC MONOCLONAL ANTIBODIES AND USE THEREOF PCT PCT PCT/US2013/055273 Expired
NIDDK E-260-2012-0-PCT-02 Cyclopentane-Peptide Nucleic Acids For Qualitative And Quantitative Detection Of Nucleic Acids PCT PCT PCT/US2013/055252 Expired
NIAID E-222-2012-0-EP-05 Use Of P47 From Plasmodium Falciparum (PfS47) Or Plasmodium Vivax (PVS47) As A Vaccine Or Drug Screening Targets For The Inhibition of Human Malaria Transmission EP National Stage 13830027.2 Abandoned
NIAID E-222-2012-0-PCT-02 Use Of P47 From Plasmodium Falciparum (Pfs47) Or A Plasmodium Vivax (PVS47) As A Vaccine Or Drug Screening Targets For The Inhibition of Human Malaria Transmission PCT PCT PCT/US2013/055372 Expired
NIMH E-345-2013-0-US-01 Monitoring The Effects Of Sleep Deprivation Using Neuronal Avalanches US 61/866,962 Abandoned
NIAID E-222-2012-0-IN-06 Use Of P47 From Plasmodium Falciparum (Pfs47) Or Plasmodium Vivax (PVS47) As A Vaccine Or Drug Screening Targets For The Inhibition of Human Malaria Transmission IN National Stage 416/KOLNP/2015 Abandoned
NIDDK E-260-2012-0-KR-04 Cyclopentane-Peptide Nucleic Acids For Qualitative And Quantitative Detection Of Nucleic Acids KR National Stage 10-2015-7006286 Abandoned
NHLBI E-253-2009-0-US-05 Composite Probes And Use Thereof in Super Resolution Methods US DIV 13/967,851 9273089 Issued PDF
NIDDK E-537-2013-0-US-01 Synthesis of Pyrrole Derivatives for Selective Inhibition of WIP1 Phosphatase US 61/865,845 Abandoned
NCI E-029-2006-1-AU-11 N-Substituted indenoisoquinolines and syntheses thereof AU DIV 2013214640 Abandoned
NIAID E-357-2001-1-AU-16 Construction of West Nile Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused By West Nile Virus AU DIV 2013213749 Abandoned
NIAID E-081-2013-3-US-01 PREFUSION RSV F PROTEINS AND THEIR USE US 61/863,909 Abandoned
NHLBI E-037-2011-0-US-03 Development Of A Novel HDL Based Hydrophobic Drug Delivery System Using Amphipathic Peptides US ORD 13/961,296 9314532 Issued PDF
NHLBI E-037-2011-0-PCT-02 Development Of A Novel HDL Based Hydrophobic Drug Delivery System Using Amphipathic Peptides PCT PCT PCT/US2013/053953 Expired
NHLBI E-037-2011-0-EP-06 Development Of A Novel HDL Based Hydrophobic Drug Delivery System Using Amphipathic Peptides EP National Stage 13751004.6 Pending
NHLBI E-553-2013-0-US-01 Aortic Access From Vena Cava for Large Caliber Transcatheter Cardiovascular Interventions US 61/863,071 Abandoned
NHLBI E-037-2011-0-AU-08 Development Of A Novel HDL Based Hydrophobic Drug Delivery System Using Amphipathic Peptides AU National Stage 2013299641 Abandoned
NHLBI E-037-2011-0-CA-05 Development Of A Novel HDL Based Hydrophobic Drug Delivery System Using Amphipathic Peptides CA National Stage 2881440 Pending
NCI E-080-2008-0-US-04 Human Monoclonal Antibodies Specific For CD22 US DIV 13/959,061 9279019 Issued PDF
NCI E-286-2006-2-US-04 Therapeutic Use of SCGB3A2 US CON 13/959,628 8828936 Issued PDF
NCI E-286-2006-3-US-01 SCGB3A2 for Treatment of Cancer US 61/862,429 Abandoned
NCATS E-050-2012-0-CA-04 Cyclodextrin For The Treatment Of Lysosomal Storage Diseases CA National Stage 2880880 Issued
NCATS E-050-2012-0-PCT-02 Cyclodextrin For The Treatment Of Lysosomal Storage Diseases PCT PCT PCT/US2013/053527 Expired
NCATS E-050-2012-0-CN-05 Cyclodextrin For The Treatment Of Lysosomal Storage Diseases CN National Stage 201380052023.0 Abandoned
NCATS E-050-2012-0-EP-06 Cyclodextrin For The Treatment Of Lysosomal Storage Diseases EP National Stage 13762617.2 Pending
NCATS E-050-2012-0-JP-07 Cyclodextrin For The Treatment Of Lysosomal Storage Diseases JP National Stage 2015-525640 Abandoned
NCATS E-050-2012-0-AU-03 Cyclodextrin For The Treatment Of Lysosomal Storage Diseases AU National Stage 2013296170 Abandoned
NHLBI E-250-2010-0-US-04 Lightguides To Simplify Total Emission Detection For Multiphoton Microscopy US National Stage 13/983,534 9448158 Issued PDF
NCI E-294-2010-0-US-03 Pharmaceutical Composition Comprising NANOG SHRNA, and Method of Using NANOG SHRNA to Treat Cancer US National Stage 13/991,989 9163236 Issued PDF
NCI E-014-2007-0-CN-28 SMOOTHENED POLYPEPTIDES AND METHODS OF USE CN DIV 201310334389.9 Abandoned
NCI E-014-2007-0-US-27 Smoothened Polypeptides and Methods of Use US DIV 13/956,628 Abandoned
NCI E-508-2013-0-US-01 Inhibitors of the Farnesoid X Receptor and Use Thereof in the Prevention of Weight Gain US 61/861,109 Abandoned